Brief: Stayble Therapeutics Raises SEK 4.55 Mln Through Issue
08/05/2025 07:11
May 8 (Reuters) - Stayble Therapeutics AB STABL.ST: COMPANY RAISES SEK 4.55 MNL THROUGH DIRECTED ISSUE Source text: ID:nWkr7LXthk Further company coverage: STABL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln